A study for a 14 year old boy who takes Vyvanse - from FDA reports


Summary

1,728 males aged 14 (±5) who take the same drug are studied. This is a personalized study for a 14 year old male patient who has Attention Deficit Hyperactivity Disorder (adhd). The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Sep, 12, 2017

1,728 males aged 14 (±5) who take Vyvanse are studied.


Number of reports submitted per year:

Vyvanse for a 14-year old boy.

Information of the patient in this study:

  • Age: 14
  • Gender: male
  • Conditions: Attention Deficit Hyperactivity Disorder (adhd)
  • Drugs taken:
    • Vyvanse (lisdexamfetamine dimesylate)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  • insomnia
  • aggression
  • tic
  • appetite - decreased
  • drug ineffective
  • suicidal ideation
  • agitation
  • disturbance in attention
  • dizziness
  • headache
1 - 6 months:
  • aggression
  • drug ineffective
  • suicidal ideation
  • weight decreased
  • appetite - decreased
  • drug effect decreased
  • insomnia
  • agitation
  • disturbance in attention
  • irritability
6 - 12 months:
  • aggression
  • suicidal ideation
  • agitation
  • affective disorder
  • abnormal behavior
  • sleep disorder
  • appetite - decreased
  • weight decreased
  • disturbance in attention
  • abdominal pain upper
1 - 2 years:
  • drug ineffective
  • drug effect decreased
  • appetite - decreased
  • insomnia
  • tic
  • gait disturbance
  • nausea
  • disturbance in attention
  • feeling abnormal
  • aggression
2 - 5 years:
  • drug effect decreased
  • drug ineffective
  • disturbance in attention
  • tic
  • weight increased
  • gynaecomastia
  • appetite - decreased
  • educational problem
  • impulsive behavior
  • aggression
5 - 10 years:
  • emotional distress
  • seizures
  • gynaecomastia
  • headache
  • appetite - decreased
  • drug ineffective
  • abdominal pain upper
  • migraine
  • learning disorder
  • weight loss
10+ years:
n/a
not specified:
  • drug ineffective
  • aggression
  • appetite - decreased
  • insomnia
  • headache
  • drug effect decreased
  • stress and anxiety
  • suicidal ideation
  • disturbance in attention
  • nausea and vomiting

Top conditions involved for these people *:

  • Affective Disorder (38 people, 2.20%)
  • Hypersensitivity (21 people, 1.22%)
  • Growth Hormone Deficiency (19 people, 1.10%)
  • Insomnia (18 people, 1.04%)
  • Bipolar Disorder (18 people, 1.04%)

Top co-used drugs for these people *:

  • Clonidine (61 people, 3.53%)
  • Intuniv (56 people, 3.24%)
  • Abilify (49 people, 2.84%)
  • Strattera (46 people, 2.66%)
  • Zoloft (41 people, 2.37%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

Related studies:

Can you answer these questions?

More questions for: Attention deficit hyperactivity disorder (adhd), Vyvanse

You may be interested in these reviews

More reviews for: Attention deficit hyperactivity disorder (adhd), Vyvanse